MBX Biosciences (MBX) Amortizatization of Intangibles (2023 - 2026)

MBX Biosciences has reported Amortizatization of Intangibles for 4 years, with the latest figure at $579000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 56.89% year-over-year to $579000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 24.44% YoY) and the FY2025 annual result came in at $3.6 million, up 23.33% from the prior year.
• Amortizatization of Intangibles rose to $579000.0 in Q1 2026 per MBX's latest filing, from $555000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $1.4 million in Q4 2024 and troughed at $441000.0 in Q2 2024.
• A 4-year average of $771800.0 and a median of $593500.0 in 2023 frame the typical range for Amortizatization of Intangibles.
• The widest YoY moves for Amortizatization of Intangibles: up 167.0% in 2025, down 60.27% in 2025.
• Over 4 years, Amortizatization of Intangibles stood at $600000.0 in 2023, then jumped by 132.83% to $1.4 million in 2024, then slumped by 60.27% to $555000.0 in 2025, then climbed by 4.32% to $579000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $579000.0, $555000.0, and $734000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.